INTRODUCTION
Diabetes is a chronic disease requiring continuous treatment and close cooperation between the physician and the patient; only on this condition can appropriate metabolic control be achieved. Large prospective clinical studies like Diabetes Control and Complications Trial (DCCT), United Kingdom Prospective Diabetes Study (UKPDS) and Kumamoto Study showed that proper glycemic control resulted in a substantial reduction of risk for chronic diabetes complications, both of micro-and macroangiopathic type [1] [2] [3] .
Glycated hemoglobin (HbA 1c ) is one of the parameters used to assess metabolic control in diabetes. It indicates a mean blood glucose concentration, showing both fasting
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form an 8-point profile on a freely selected day. The profile included the following measurements: before breakfast, 2 hours after breakfast, before lunch, 2 hours after lunch, before dinner, 2 hours after dinner, at bedtime and at 3:00 AM. Each patient determined the frequency of their own SMBG,which served as the basis for division into the following groups: A -minimum 5 measurements per day B -3-4 measurements per day C -1-2 measurements per day D -1-2 measurements per week E -1-2 measurements per month F -no SMBG.
In all patients glycated hemoglobin was measured using the Bio-RAD Variant high-performance liquid chromatography (HPLC).
Statistical analysis
The calculations were made with STATISTICA 6.0 PL (Tulsa, OK, United States) software. We used the χ 2 test and analysis of variance (ANOVA). The value of p<0.05 was considered statistically significant.
RESULTS
All patients monitored blood glucose before and after breakfast, and almost all of them also after lunch and dinner. Night monitoring was performed by less than 50% of the patients. The details of SMBG in the whole study group are presented in Table 1 .
The mean HbA 1c value in the whole studied group was 7.45% (SD = 1.08). Diabetes control recommended by PTD (HbA 1c ≤6.5%) was achieved only by 20% of the patients. No statistically significant difference in the mean HbA 1c value was observed between women (7.42%, SD = 1.08) and men a month [6] . Self-monitoring at the beginning of pharmacological treatment, as well as during the change of medication and each relapse of the disease is of significance. It seems that glycemia measurements frequently made by the patient should lead to proper diabetes control, however, the studies assessing the influence of self-monitoring on the control of carbohydrate management in type 2 diabetes do not provide inconsistent results.
The objective of the study was to assess a relationship between the frequency of SMBG and HbA 1c values. The relation was assessed in type 2 diabetes patients to find out whether frequent SMBG allows to achieve lower glucose levels, thus enabling to achieve better treatment outcomes.
PATIENTS AND METHODS
The study involved 600 consecutive type 2 diabetes patients who were referred to the Voivodeship Diabetes Clinic in Łódź. The follow-up involved patients of both sexes, irrespective of age, education, diabetes duration and methods of treatment.
The mean age of the patients was 63.4 years (32-85 years, standard deviation [SD] = 9.0). The study group included 319 females aged 32-85 years (mean 64.9, SD = 8.8) and 281 males aged 35-83 years (mean 61.7, SD = 8.9). The mean diabetes duration in the study group was 11.4 years (SD = 7.7). The most frequent duration was 11-20 years. The patients were undergoing standard diabetes education provided by the clinic personnel.
A group of 397 (66.2%) patients was treated with insulin as monotherapy or in combination with oral medications; others were administered only oral medications.
The patients were requested to perform SMBG with their own glucometer. All patients were obliged to record maximum and minimum glucose levels during the last week and to per- The mean values of maximum and minimum glucose and HbA 1c levels (Table 2) did not vary significantly in the individual groups. During the study, the patients did not report serious hypoglycemia, i.e. glycemia <40 mg/dl, neither did they require assistance.
The χ 2 test of independence did not show a statistically significant association between SMBG frequency and HbA 1c value in the individual groups. Similarly, the ANOVA did not show differences in HbA 1c values between the studied groups (p = 0.27; Fig. 1 ). The relation between HbA 1c values and SMBG frequency was also analyzed in 2 groups ie. that receiving insulin and that on oral hypoglycemic medication. All patients were on standard insulin therapy.
For the insulin group, χ 2 test of independence (HbA 1c values categorized by intervals) showed no statistically significant association between SMBG frequency and HbA 1c value (p = 0.63). ANOVA results, additionally obtained for 6 groups selected in respect of SMBG frequency, showed no differences in HbA 1c values in the insulin group (p = 0.16; Fig. 2) .
Similarly, the oral medication group did not show statistically significant differences between HbA 1c values and SMBG frequency (χ 2 test of independence, p = 0.10; ANOVA, p = 0.15). The results are shown in Figure 3 .
DISCUSSION
Self-monitoring of blood glucose is a recognized diabetes monitoring method. It is recommended for patients in order to achieve the desired glucose levels, prevent hypo-and hyperglycemic incidents, and thus to prevent acute and chronic diabetic complications. This method is definitely recommended for insulin patients and patients on alternative treatment.
It was demonstrated that self-monitoring in type 1 diabetes patients undergoing intensive insulin therapy is associated with improved glycemia, which enables to achieve lower HbA 1c values [7] . There is an ongoing discussion whether such self-monitoring is justified in type 2 diabetes, in patients ORIGINAL ARTICLES p <0.0001) than in patients performing SMBG once per day [17] . One of the large observational studies showed a relation between SMBG performed at home and significantly lower HbA 1c levels both in type 1 (n = 1159; SMBG 3 times per day; reduction in HbA 1c levels by 1%, p <0.001), and type 2 diabetes patients (n = 23,153; SMBG at least once per day; reduction in HbA 1c levels by 0.4-0.6%) [18] . For type 2 diabetes, the relation was found both in patients treated with insulin and those treated only with oral medications or diet. In patients who performed SMBG irrespective of frequency, HbA 1c levels were by 0.4% lower than in patients not performing SMBG (p <0.0001) and decreased with the increase in SMBG frequency. Also a large RCT carried out by Schwedes et al. [19] , involving type 2 diabetes patients treated with oral medications or diet, showed a significantly higher reduction in HbA 1c values in patients performing SMBG than in patients not performing SMBG (1% vs. 0.6%, p <0.05). A similar relation was demonstrated in a study by Guerci et al. [20] (0.9% vs. 0.5%, p <0.05). Based on results of the studies carried out to date, no clear-cut answer could be provided to the question as to whether intensive SMBG is justified in type 2 diabetes patients. However, there is a relatively small number of studies showing such an association, and the authors of those studies suggest to approach the results carefully, indicating study design limitations associated with heterogeneity of the studied by 0.9%, p <0.05) [9] . Only 8 out of 18 studies published between 1990 and 1999 pertained to RCTs (including 6 published by Faas). A meta-analysis of 4 studies demonstrated that performing SMBG results in a slight and insignificant reduction in mean HbA 1c levels (by 0.6% at most). The results should, however, be interpreted carefully due to study design limitations of the trials included in the meta-analysis [10] .
Results similar to our study have been shown in numerous other studies. A study carried out in England and involving 290 type 2 diabetes patients treated with insulin did not show an association between HbA 1c reduction and SMBG frequency [11] . Other centers did not show such a relation either, irrespective of the type of therapy in type 2 diabetes [12] [13] [14] . Recent DiGEM RCTs completed in 2007 and a study by Davidson carried out in 2005, likewise did not show significant differences in HbA 1c values between patients performing and not performing SMBG [15, 16] .
A study from Germany and Austria on type 2 diabetes patients treated with insulin showed a significant HbA 1c reduction (by 0.16%) in patients performing SMBG more frequently (average of 2.7 per day) in comparison with patients performing SMBG once a day. In patients treated with diet or oral medications who performed SMBG twice per day, HbA 1c values were significantly higher (increase by 0.14%, populations and undertaken interventions. Therefore, the following question shall be raised: how often and at what times of the day SMBG is to be performed to achieve a satisfactory level of metabolic control in type 2 diabetes? The studies carried out to date do not provide unambiguous hints, although some reports suggest that in order to answer the aforementioned question it is essential to use SMBG results appropriately, both by the physician and the patient, which in this case requires appropriate education of the patient [21] .
It is not, however, the fact of SMBG performance itself, but a correlation between the results obtained by the patient and health measures taken by him/her, which may lead to improvement of treatment efficacy. It was demonstrated in a randomized study by Moreland et al. [22] which answered the question whether SMBG education contributed to the improvement of glucose level and an increase in SMBG frequency. All 199 diabetic patients (type 1 -35%, type 2 -65%, HbA 1c ≥8.0%) were divided into 3 groups: patients receiving a glucometer and education, patients receiving a glucometer without education and a standard group without a glucometer and education. The highest reduction in HbA 1c values were observed in patients performing SMBG who received education (-0.13 ±1.28%), lower in patients performing SMBG without education (-0.04 ±1.31%). In patients not performing SMBG and not receiving education, an increase in glycated hemoglobin was observed (+0.04 ±-1.10%)
Education of patients should therefore constitute an integral part of diabetes treatment, because only competent use of information coming from current blood glucose allows optimization of frequency and costs of self-monitoring. A methodology of self-monitoring education remains an open question.
In conclusion, no relation between SMBG frequency and glycemic control level undermines the usefulness of repeated monitoring in all type 2 diabetes patients. It seems that performance of expensive SMBG must be combined with intensive education of patients.
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